Scarica l'app Stockscreener
2.33
4.12%
-0.10
Precedente Chiudi:
$2.43
Aprire:
$2.4
Volume 24 ore:
129.74K
Relative Volume:
0.61
Capitalizzazione di mercato:
$116.14M
Reddito:
-
Utile/perdita netta:
$-6.48M
Rapporto P/E:
-17.01
EPS:
-0.137
Flusso di cassa netto:
$-5.30M
1 W Prestazione:
-17.08%
1M Prestazione:
+3.10%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$2.25
$2.44
Intervallo di 1 settimana:
$2.25
$2.88
Portata 52W:
$2.01
$33.90
Polaryx Therapeutics Inc Stock (PLYX) Company Profile
Nome
Polaryx Therapeutics Inc
Settore
Industria
Telefono
201-940-7236
Indirizzo
140 EAST RIDGEWOOD AVENUE, PARAMUS
Compare PLYX vs VRTX, REGN, ARGX, ALNY, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PLYX
Polaryx Therapeutics Inc
|
2.33 | 116.14M | 0 | -6.48M | -5.30M | -0.137 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Polaryx Therapeutics Inc Stock (PLYX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-27 | Iniziato | Maxim Group | Buy |
Polaryx Therapeutics Inc Borsa (PLYX) Ultime notizie
PLYX News Today | Why did Polaryx Therapeutics stock drop today? - MarketBeat
H.C. Wainwright initiates Polaryx Therapeutics stock with buy rating By Investing.com - Investing.com Nigeria
H.C. Wainwright initiates Polaryx Therapeutics stock with buy rating - Investing.com
PLYX Initiates Coverage On Polaryx Therapeutics -- Price Target Set at $7.00 - GuruFocus
Polaryx Therapeutics Initiated at Buy by HC Wainwright & Co. - Moomoo
Operating cash flow per share of Polaryx Therapeutics, Inc. – FWB:1V8 - TradingView
Free cash flow per share of Polaryx Therapeutics, Inc. – FWB:1V8 - TradingView
Polaryx Therapeutics (PLYX) Holds Steady Near Support as Technical Indicators Signal ConsolidationDeath Cross - dars.gov.et
Polaryx Therapeutics (PLYX) Stock Analysis Report | Financials & Insights - Benzinga España
Enterprise value to EBIT forward of Polaryx Therapeutics, Inc. – NASDAQ:PLYX - TradingView
Enterprise value to revenue forward of Polaryx Therapeutics, Inc. – NASDAQ:PLYX - TradingView
Price to sales forward of Polaryx Therapeutics, Inc. – NASDAQ:PLYX - TradingView
Price to earnings forward of Polaryx Therapeutics, Inc. – NASDAQ:PLYX - TradingView
Polaryx Therapeutics, Inc. Actuals & Estimates (NASDAQ:PLYX) - TradingView
PLYX Forecast — Price Target — Prediction for 2027 - TradingView
PLYX Stock Rockets To Best Day Ever: Why Retail Traders Are Piling Into This Battered Biotech - Stocktwits
Polaryx Therapeutics Ord Shs (PLYX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Polaryx Therapeutics Ord Shs (PLYX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Polaryx Therapeutics Ord Shs (PLYX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Polaryx Therapeutics Ord Shs (PLYX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Polaryx Therapeutics Ord Shs - TradingKey
Polaryx Therapeutics Ord Shs (PLYX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Polaryx Therapeutics Ord Shs (PLYX) Institutional Confidence - TradingKey
Polaryx Therapeutics Inc (PLYX) Stock Price, Quote, News & History - Benzinga
Polaryx Therapeutics (PLYX) Short Interest & Short Float | Updated Jun 2026 - MarketBeat
Polaryx Therapeutics (PLYX) Faces Pressure After 6.7% Drop: Key Support Levels in FocusHead and Shoulders - newsline.com
Polaryx Therapeutics, Inc. Common Stock (PLYX) Stock Forecast & Price Prediction 2026–2030 - CoinCodex
Polaryx Therapeutics (PLYX) Stock Chart and Price History 2026 - MarketBeat
Polaryx Therapeutics CEO’s Mstone buys $360,003 in PLYX stock By Investing.com - Investing.com Australia
Polaryx Therapeutics (PLYX) Insider Trading Activity 2026 - MarketBeat
Polaryx Therapeutics CEO’s Mstone buys $360,003 in PLYX stock - Investing.com
MStone affiliate of Polaryx Therapeutics (PLYX) buys 88K common shares - Stock Titan
PLYXPolaryx Therapeutics Inc. stock news, filings & ratings - Quantisnow
Polaryx (PLYX) secures $10M PIPE to fund SOTERIA trial and extend runway to Q2 2027 - Stock Titan
Why Polaryx Therapeutics Stock Is Surging On Thursday? - Benzinga
Polaryx Therapeutics closes $10 million PIPE financing By Investing.com - Investing.com Nigeria
Polaryx Therapeutics closes $10 million PIPE financing - Investing.com
Polaryx Therapeutics Announces Closing of $10 Million Private Placement Equity Financing to Support Launch of SOTERIA Phase 2 Basket Trial - marketscreener.com
Polaryx Therapeutics (PLYX) Surges Nearly 20%: Key Levels to Watch After the BreakoutCovered Call Trade - dars.gov.et
Polaryx Therapeutics, Inc. announced that it has received $10.010784 million in funding - marketscreener.com
Polaryx Therapeutics (PLYX) Slips 2.71% as Stock Tests Key Support Near $2.38Growth ETF - The Legal Advocate
Polaryx Therapeutics (PLYX) Retreats Toward Support Amid Selling PressureETF Outflow Streak - Město Břeclav
thanks & goodnight ! - Moomoo
Polaryx Therapeutics (PLYX) Slips 8.63% as Biotech Volatility Resurfaces – Key Support Levels in FocusFactor Valuation - dars.gov.et
PLYX Technical Analysis | Trend, Signals & Chart Patterns | POLARYX THERAPEUTICS INC (NASDAQ:PLYX) - ChartMill
Polaryx Therapeutics, Inc. Q1 2026 Financial Results and Pipeline Update: Progress in Rare Pediatric Lysosomal Storage Disorder Therapies - Minichart
Polaryx Therapeutics (NASDAQ: PLYX) narrows loss but flags going concern risk - Stock Titan
Polaryx Therapeutics 1Q 2026: Net income $(2.54M), EPS $(0.05) — 10-Q Summary - TradingView
Polaryx Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Polaryx Therapeutics Awarded Double Honors at the 2026 GHP Healthcare & Pharmaceutical Awards - Quiver Quantitative
Polaryx Therapeutics Receives GHP Magazine’s Healthcare & Pharmaceuticals Awards - The Manila Times
Polaryx Therapeutics Inc Azioni (PLYX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.64%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):